Delivery Order SPE2DB22D3004-SPE2DB25FRU90
- Not listed
- The Defense Logistics Agency awarded a $1,842.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL quantities. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is non-competitive and scheduled for completion by August 1, 2025. Performance will be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.94 to AmerisourceBergen Drug Corp for Loteprednol Etabonate 0.5% ophthalmic drops (5 mL) on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- This is a $1,776.60 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL containers. The contract is a Firm Fixed Price agreement with a completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This delivery order, valued at $2,630.16, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp for the supply of Loteprednol Etabonate 0.5% ophthalmic suspension. The contract is a firm fixed-price delivery order issued under the Defense Logistics Agency's Medical Supply Chain program, with performance to be completed by August 19, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis, consistent with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.23 delivery order contract is for the supply of the pharmaceutical product Loteprednol Etabonate 0.5% Ophthalmic Drops, 5 ML. The contract is not designated as a set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds...
- This is a firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Loteprednol Etabonate 0.5% ophthalmic drops in 10 milliliter volumes. The total ceiling value of this order is $2,128.80. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of a pharmaceutical product, loteprednol etabonate 0.2% eye drops, with a ceiling value of $3,286.90 and a period of performance through April 5, 2024. The contract is a firm fixed price delivery order with no set-aside...
- This is a $3,964.93 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of LOTEPREDNOL ETABONATE 0.5% DRP 10ML, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Loteprednol Etabonate 0.5% eye drops in 5 mL containers. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on September 16, 2021, with a completion date of September 17, 2021. The ceiling value of the fixed-price delivery order is $5,728.77. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.82 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% ophthalmic drops (5ml). The contract was awarded on September 7, 2021, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRU90Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in a 5 mL unit, with a ceiling value of $1,267.04. This competitive award utilizes a firm fixed price structure and is classified as a child contract under a larger vehicle. The performance location is identified as Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. No set-aside designation was applied to this procurement. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The company serves critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard through this flexible contract vehicle designed to meet the Department of Defense's medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/4/25 |